In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp. (Q33758936)

29 July 2017

title

In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp. (English)

1 reference

29 July 2017

1 reference

Pendland SL

1

1 reference

29 July 2017

Piscitelli SC

series ordinal

2

1 reference

29 July 2017

Schreckenberger PC

series ordinal

3

1 reference

29 July 2017

Danziger LH

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

2106-2110

1 reference

The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Decimal assay for additivity of drugs permits delineation of synergy and antagonism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Symposium on antimicrobial agents. Metronidazole

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

A review of cephalosporin metabolism: a lesson to be learned for future chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Newer beta-lactam agents and the Bacteroides fragilis group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284692

The isolation and identification of the urinary oxidative metabolites of metronidazole in man

21 June 2018

1 reference

12 December 2020

Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds

1 reference

12 December 2020

The fractional inhibitory concentration (FIC) index as a measure of synergy

1 reference

12 December 2020

Influence of dose and route of administration on disposition of metronidazole and its major metabolites

1 reference

12 December 2020

1 reference

12 December 2020

Susceptibility of anaerobic bacteria to antimicrobial agents

1 reference

12 December 2020

Twelve-hourly dosage schedule for oral and intravenous metronidazole

1 reference

12 December 2020

The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactericidal tests

1 reference

12 December 2020

Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin

1 reference

12 December 2020

Metronidazole and anaerobic sepsis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.38.9.2106

1 reference

29 July 2017

1 reference

29 July 2017

1 reference